TJ Biotech Holding ApS: Financial statements 2025
CVR: 41953616
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
TJ Biotech Holding ApS (CVR 41953616) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. That is a decrease of 40.4% compared with the year before. Equity in the 2025 report amounted to DKK 18,607,145. The solvency ratio was 77.8%.
- Gross Profit
- DKK 70,424
- Profit/Loss
- DKK 4,184,576
- Equity
- DKK 18,607,145
- Total Assets
- DKK 23,928,445
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 70K | 4.2M | 18.6M | 0 |
| 2024 | - | 118K | 668K | 14.4M | 0 |
| 2023 | - | 70K | -9.5M | 13.8M | 0 |
| 2022 | - | 54K | -216K | 23.3M | 0 |
| 2021 | - | 1.7M | 413K | 23.5M | 1 |
Official annual report
How creditworthy is TJ Biotech Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
TJ Biotech Holding ApS has published its annual report for 2024. Gross profit came to DKK 118,224, and the net result was DKK 667,738.
About TJ Biotech Holding ApS
TJ Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Engelbrecht Nordkild Jonassen. The company is owned by Thomas Engelbrecht Nordkild Jonassen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. Equity in the 2025 report amounted to DKK 18,607,145.
